BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19838951)

  • 1. Desmin expression in human cardiomyocytes and selected clinical and echocardiographic parameters in patients with chronic heart failure.
    Pawlak A; Gil RJ; Walczak E; Seweryniak P
    Kardiol Pol; 2009 Sep; 67(9):955-61. PubMed ID: 19838951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte desmin abnormalities - an accurate predictor of long-term survival in patients with chronic heart failure.
    Pawlak A; Gil RJ; Kasprzak J; Walczak E; Słysz A
    Kardiol Pol; 2009 Jul; 67(7):724-33. PubMed ID: 19649994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of desmin activity using immunohistochemical and immunofluorescent staining of myocardial biopsies in patients with chronic heart failure. Comparison of the two methods.
    Pawlak A; Gil RJ; Walczak E; Fidziańska A
    Kardiol Pol; 2007 Mar; 65(3):229-35; discussion 236. PubMed ID: 17436150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type of desmin expression in cardiomyocytes - a good marker of heart failure development in idiopathic dilated cardiomyopathy.
    Pawlak A; Gil RJ; Kulawik T; Pronicki M; Karkucińska-Więckowska A; Szymańska-Dębińska T; Gil K; Lagwinski N; Czarnowska E
    J Intern Med; 2012 Sep; 272(3):287-97. PubMed ID: 22292457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure.
    Di Somma S; Di Benedetto MP; Salvatore G; Agozzino L; Ferranti F; Esposito S; La Dogana P; Scarano MI; Caputo G; Cotrufo M; Santo LD; de Divitiis O
    Eur J Heart Fail; 2004 Jun; 6(4):389-98. PubMed ID: 15182762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of low desmin expression in cardiomyocytes in patients with idiopathic dilated cardiomyopathy.
    Pawlak A; Gil RJ; Grajkowska W; Nasierowska-Guttmejer AM; Rzezak J; Kulawik T
    Am J Cardiol; 2013 Feb; 111(3):393-9. PubMed ID: 23178054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural morphometric findings of cardiomyocytes in patients with impaired ventricular function--a comparative clinicopathological study.
    Wassilew K; Terziev D; Wassilew G; Fitzl G; Frölich K; Kandolf R; Fried A
    Cardiovasc Pathol; 2016; 25(1):25-32. PubMed ID: 26472277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cytoskeletal, linkage and extracellular proteins in failing dog myocardium.
    Sharov VG; Kostin S; Todor A; Schaper J; Sabbah HN
    Heart Fail Rev; 2005 Dec; 10(4):297-303. PubMed ID: 16583178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Desmin as predictor of survival in patients with chronic heart failure].
    Wojnicz R
    Kardiol Pol; 2009 Jul; 67(7):734. PubMed ID: 19750605
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: II. Cytoskeletal remodeling.
    Wang X; Li F; Campbell SE; Gerdes AM
    J Mol Cell Cardiol; 1999 Feb; 31(2):319-31. PubMed ID: 10093045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters.
    Kouris NT; Zacharos ID; Kontogianni DD; Goranitou GS; Sifaki MD; Grassos HE; Kalkandi EM; Babalis DK
    Eur J Heart Fail; 2005 Mar; 7(2):199-203. PubMed ID: 15701467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of additional improvement in outcome of patients receiving cardiac resynchronization therapy paced at the most delayed left ventricular region.
    Deplagne A; Lafitte S; Reuter S; Reant P; Ploux S; Mokrani B; Roudaut R; Jais P; Haissaguerre M; Clementy J; DosSantos P; Bordachar P
    Arch Cardiovasc Dis; 2009; 102(8-9):641-9. PubMed ID: 19786268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the ultrastructural and immunohistochemical analysis of cardiac biopsy in affected heart.
    Fidziańska A; Glinka-Lindner Z; Religa G; Walczak E
    Folia Neuropathol; 2010; 48(1):57-63. PubMed ID: 20383812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain.
    Logeart D; Beyne P; Cusson C; Tokmakova M; Leban M; Guiti C; Bourgoin P; Solal AC
    Am Heart J; 2001 Feb; 141(2):247-53. PubMed ID: 11174339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of ultrastructure and cytoskeleton during progression of cardiac hypertrophy to heart failure.
    Gupta A; Gupta S; Young D; Das B; McMahon J; Sen S
    Lab Invest; 2010 Apr; 90(4):520-30. PubMed ID: 20157292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure.
    Yndestad A; Landrø L; Ueland T; Dahl CP; Flo TH; Vinge LE; Espevik T; Frøland SS; Husberg C; Christensen G; Dickstein K; Kjekshus J; Øie E; Gullestad L; Aukrust P
    Eur Heart J; 2009 May; 30(10):1229-36. PubMed ID: 19329498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
    Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
    Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study).
    Ghio S; Freemantle N; Serio A; Magrini G; Scelsi L; Pasotti M; Cleland JG; Tavazzi L
    Eur J Echocardiogr; 2006 Oct; 7(5):373-8. PubMed ID: 16337208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure.
    Husberg C; Nygård S; Finsen AV; Damås JK; Frigessi A; Oie E; Waehre A; Gullestad L; Aukrust P; Yndestad A; Christensen G
    J Mol Cell Cardiol; 2008 Aug; 45(2):261-9. PubMed ID: 18585734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.